Wave Life Sciences Ltd.
NASDAQ:WVE
5.47 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 113.305 | 3.649 | 40.964 | 20.077 | 15.983 | 14.414 | 3.704 | 1.485 | 0.152 | 0 | 0 |
| Kosten van de omzet
| 9.206 | 10.114 | 121.875 | 124.165 | 175.431 | 134.428 | 79.309 | 0.393 | 9.057 | 2.395 | 4.608 |
| Brutowinst
| 104.099 | -6.465 | -80.911 | -104.088 | -159.448 | -120.014 | -75.605 | 1.092 | -8.905 | -2.395 | -4.608 |
| Brutowinstmarge
| 0.919 | -1.772 | -1.975 | -5.184 | -9.976 | -8.326 | -20.412 | 0.735 | -58.586 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 130.009 | 115.856 | 121.875 | 130.944 | 175.431 | 134.428 | 79.309 | 40.818 | 9.057 | 2.395 | 1.92 |
| Algemene en administratieve kosten
| 51.292 | 50.513 | 46.105 | 42.51 | 48.869 | 39.509 | 26.975 | 15.994 | 10.393 | 2.999 | 1.654 |
| Verkoop- en marketingkosten
| -9.206 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 42.086 | 50.513 | 46.105 | 42.51 | 48.869 | 39.509 | 26.975 | 15.994 | 10.393 | 2.999 | 1.654 |
| Overige kosten
| 1.878 | 0.007 | 4.537 | 2.058 | 9.738 | 9.549 | -0.331 | -0.05 | 0.056 | 0.261 | 0.037 |
| Bedrijfskosten
| 172.095 | 166.369 | 167.98 | 173.454 | 224.3 | 173.937 | 106.284 | 56.812 | 19.45 | 5.394 | 3.574 |
| Bedrijfsresultaat
| -67.996 | -162.72 | -127.016 | -153.377 | -208.317 | -159.523 | -102.58 | -55.327 | -19.298 | -5.394 | -3.574 |
| Bedrijfsresultaat ratio
| -0.6 | -44.593 | -3.101 | -7.639 | -13.034 | -11.067 | -27.694 | -37.257 | -126.961 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 9.806 | 1.578 | 4.567 | 2.626 | 14.679 | 12.917 | 1.247 | 0.205 | 0.056 | 0.261 | 0.037 |
| Inkomen voor belasting
| -58.19 | -161.142 | -122.449 | -150.751 | -193.638 | -146.584 | -101.327 | -54.785 | -19.156 | -5.145 | -3.648 |
| Inkomen voor belasting ratio
| -0.514 | -44.161 | -2.989 | -7.509 | -12.115 | -10.17 | -27.356 | -36.892 | -126.026 | 0 | 0 |
| Belastingkosten
| -0.677 | 0.681 | -0.204 | -0.841 | -14.142 | 0.069 | 0.708 | 0.616 | 0.044 | 0.084 | -0.33 |
| Nettowinst
| -57.513 | -161.823 | -122.245 | -149.91 | -179.496 | -146.653 | -102.035 | -55.401 | -19.2 | -5.229 | -3.318 |
| Nettowinstmarge
| -0.508 | -44.347 | -2.984 | -7.467 | -11.23 | -10.174 | -27.547 | -37.307 | -126.316 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.54 | -2.05 | -2.36 | -3.82 | -5.3 | -5.06 | -3.85 | -2.43 | -1.83 | -0.25 | -0.16 |
| Verwaterde WPA
| -0.54 | -2.05 | -2.36 | -3.82 | -5.3 | -5.06 | -3.85 | -2.43 | -1.83 | -0.25 | -0.16 |
| EBITDA
| -58.79 | -162.72 | -127.046 | -153.961 | -213.229 | -157.31 | -102.003 | -55.582 | -18.704 | -4.852 | -3.298 |
| EBITDA ratio
| -0.519 | -44.593 | -3.101 | -7.669 | -13.341 | -10.914 | -27.539 | -37.429 | -123.053 | 0 | 0 |